Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Addendum Free access | 10.1172/JCI73496

Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia

Dana M. Cairns, Robert J. Pignolo, Tomoya Uchimura, Tracy A. Brennan, Carter M. Lindborg, Meiqi Xu, Frederick S. Kaplan, Eileen M. Shore, and Li Zeng

Find articles by Cairns, D. in: PubMed | Google Scholar

Find articles by Pignolo, R. in: PubMed | Google Scholar

Find articles by Uchimura, T. in: PubMed | Google Scholar

Find articles by Brennan, T. in: PubMed | Google Scholar

Find articles by Lindborg, C. in: PubMed | Google Scholar

Find articles by Xu, M. in: PubMed | Google Scholar

Find articles by Kaplan, F. in: PubMed | Google Scholar

Find articles by Shore, E. in: PubMed | Google Scholar

Find articles by Zeng, L. in: PubMed | Google Scholar

Published November 1, 2013 - More info

Published in Volume 123, Issue 11 on November 1, 2013
J Clin Invest. 2013;123(11):4981–4981. https://doi.org/10.1172/JCI73496.
© 2013 The American Society for Clinical Investigation
Published November 1, 2013 - Version history
View PDF

Related article:

Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia
Dana M. Cairns, Robert J. Pignolo, Tomoya Uchimura, Tracy A. Brennan, Carter M. Lindborg, Meiqi Xu, Frederick S. Kaplan, Eileen M. Shore, Li Zeng
Dana M. Cairns, Robert J. Pignolo, Tomoya Uchimura, Tracy A. Brennan, Carter M. Lindborg, Meiqi Xu, Frederick S. Kaplan, Eileen M. Shore, Li Zeng
Research Article Genetics

Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia

  • Text
  • PDF
Abstract

Progressive osseous heteroplasia (POH) is a rare developmental disorder of heterotopic ossification (HO) caused by heterozygous inactivating germline mutations in the paternal allele of the GNAS gene. Interestingly, POH lesions have a bewildering mosaic distribution. Using clinical, radiographic, and photographic documentation, we found that most of the 12 individuals studied had a lesional bias toward one side or the other, even showing exclusive sidedness. Most strikingly, all had a dermomyotomal distribution of HO lesions. We hypothesized that somatic mutations in a progenitor cell of somitic origin may act on a background of germline haploinsufficiency to cause loss of heterozygosity at the GNAS locus and lead to the unilateral distribution of POH lesions. Taking advantage of the chick system, we examined our hypothesis by mimicking loss of heterozygosity of GNAS expression using dominant-negative GNAS that was introduced into a subset of chick somites, the progenitors that give rise to dermis and muscle. We observed rapid ectopic cartilage and bone induction at the axial and lateral positions in a unilateral distribution corresponding to the injected somites, which suggests that blocking GNAS activity in a targeted population of progenitor cells can lead to mosaic ectopic ossification reminiscent of that seen in POH.

Authors

Dana M. Cairns, Robert J. Pignolo, Tomoya Uchimura, Tracy A. Brennan, Carter M. Lindborg, Meiqi Xu, Frederick S. Kaplan, Eileen M. Shore, Li Zeng

×

Original citation: J. Clin. Invest. 2013;123(8):3624–3633. doi:10.1172/JCI69746.

Citation for this addendum: J. Clin. Invest. 2013;123(11):4981. doi:10.1172/JCI73496.

Since the publication of the article, the authors have learned that a prior publication reported on patient 5 in an independent research study. Following standard procedures to maintain confidentiality, the authors were unaware that the patient was a participant in a separate study at the time the article was prepared; they became aware when they were contacted by the authors of the prior publication. In the interest of providing more complete information regarding reported subjects, they wish to add a note of this report in Methods. The correct additional sentence is below.

Patient 5 was evaluated for this study at the University of Pennsylvania Orthopaedic Surgery Outpatient Clinic; this individual was also previously described as patient 1 in a prior publication (51).

51. Lebrun M, et al. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab. 2010;95(6):3028–3038.

The authors anticipate that this information will provide a more complete view of the patient and disease to the scientific and medical community.

Version history
  • Version 1 (November 1, 2013): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts